SinoMab BioScience: Share option scheme update

SinoMab BioScience, a Hong Kong-incorporated company, announced movements in its share option scheme for the month ended June 30, 2025. According to the report, the number of share options outstanding decreased due to the lapsing and cancellation of options. Specifically, 850,000 options lapsed, and 30,187,200 were cancelled. As a result, the number of share options outstanding at the end of June stood at 22,673,600. The company reports no new shares were issued during the month pursuant to the option scheme. The total number of shares which may be issued or transferred out of treasury upon exercise of all share options to be granted under the scheme at close of the month is 99,113,111. The share option scheme was approved on October 26, 2022, and amended on June 14, 2024. No funds were raised during the month from the exercise of options.